Rezultati - Matthias Mayerhofer
- Showing 1 - 20 results of 20
-
1
Transcriptome analysis of human cancer reveals a functional role of Heme Oxygenase-1 in tumor cell adhesion od Stefanie Tauber, Alexander Jaïs, Markus Jeitler, Sandra Haider, Julia Husa, Josefine Lindroos, Martin Knöfler, Matthias Mayerhofer, Hubert Pehamberger, Oswald Wagner, Martin Bilban
Izdano 2010Artigo -
2
Identification of Basophils as a Major Source of Hepatocyte Growth Factor in Chronic Myeloid Leukemia: A Novel Mechanism of BCR-ABL1-Independent Disease Progression od Sabine Cerny‐Reiterer, Viviane Ghanim, Gregor Hoermann, Karl J. Aichberger, Harald Herrmann, Leonhard Muellauer, Andreas Repa, Christian Sillaber, Andrew F. Walls, Matthias Mayerhofer, Peter Valent
Izdano 2012Artigo -
3
Digital PCR: A Sensitive and Precise Method for KIT D816V Quantification in Mastocytosis od Georg Greiner, Michael Gurbisz, Franz Ratzinger, Nadine Witzeneder, Ingrid Simonitsch‐Klupp, Gerlinde Mitterbauer‐Hohendanner, Matthias Mayerhofer, Leonhard Müllauer, Wolfgang R. Sperr, Peter Valent, Gregor Hoermann
Izdano 2017Artigo -
4
Cardiac Glycosides Induce Cell Death in Human Cells by Inhibiting General Protein Synthesis od Andrea Perné, Markus K. Muellner, Magdalena Steinrueck, Nils Craig-Mueller, Julia Mayerhofer, Ilse Schwarzinger, Mathew A. Sloane, Iris Z. Uras, Gregor Hoermann, Sebastian Nijman, Matthias Mayerhofer
Izdano 2009Artigo -
5
Polo-like Kinase 1 (Plk1) as a Novel Drug Target in Chronic Myeloid Leukemia: Overriding Imatinib Resistance with the Plk1 Inhibitor BI 2536 od Karoline V. Gleixner, Veronika Ferenc, Barbara Peter, Alexander Gruze, Renata A. Meyer, Emir Hadzijusufovic, Sabine Cerny‐Reiterer, Matthias Mayerhofer, Winfried F. Pickl, Christian Sillaber, Peter Valent
Izdano 2010Artigo -
6
Identification of MCL1 as a novel target in neoplastic mast cells in systemic mastocytosis: inhibition of mast cell survival by MCL1 antisense oligonucleotides and synergism with P... od Karl J. Aichberger, Matthias Mayerhofer, Karoline V. Gleixner, Maria‐Theresa Krauth, Alexander Gruze, Winfried F. Pickl, Volker Wacheck, Edgar Selzer, Leonhard Müllauer, Hermine Agis, Christian Sillaber, Peter Valent
Izdano 2006Artigo -
7
Identification of Heme Oxygenase-1 As a Novel BCR/ABL-Dependent Survival Factor in Chronic Myeloid Leukemia od Matthias Mayerhofer, Stefan Florian, Maria‐Theresa Krauth, Karl J. Aichberger, Martin Bilban, Rodrig Marculescu, Dieter Printz, G. Fritsch, Oswald Wagner, Edgar Selzer, Wolfgang R. Sperr, Peter Valent, Christian Sillaber
Izdano 2004Artigo -
8
Identification of proapoptotic Bim as a tumor suppressor in neoplastic mast cells: role of KIT D816V and effects of various targeted drugs od Karl J. Aichberger, Karoline V. Gleixner, Irina Mirkina, Sabine Cerny‐Reiterer, Barbara Peter, Veronika Ferenc, Michael Kneidinger, Christian Baumgärtner, Matthias Mayerhofer, Alexander Gruze, Winfried F. Pickl, Christian Sillaber, Peter Valent
Izdano 2009Artigo -
9
PKC412 inhibits in vitro growth of neoplastic human mast cells expressing the D816V-mutated variant of KIT: comparison with AMN107, imatinib, and cladribine (2CdA) and evaluation o... od Karoline V. Gleixner, Matthias Mayerhofer, Karl J. Aichberger, Sophia Derdak, Karoline Sonneck, Alexandra Böhm, Alexander Gruze, Puchit Samorapoompichit, Paul W. Manley, Doriano Fabbro, Winfried F. Pickl, Christian Sillaber, Peter Valent
Izdano 2005Artigo -
10
Expression of Activated STAT5 in Neoplastic Mast Cells in Systemic Mastocytosis od Christian Baumgärtner, Sabine Cerny‐Reiterer, Karoline Sonneck, Matthias Mayerhofer, Karoline V. Gleixner, Richard R. Fritz, Marc A. Kerenyi, Cédric Boudot, Fabrice Gouilleux, Jan‐Wilhelm Kornfeld, Christian Sillaber, Richard Moriggl, Peter Valent
Izdano 2009Artigo -
11
Synergistic growth-inhibitory effects of two tyrosine kinase inhibitors, dasatinib and PKC412, on neoplastic mast cells expressing the D816V-mutated oncogenic variant of KIT od Karoline V. Gleixner, Matthias Mayerhofer, Karoline Sonneck, Alexander Gruze, Puchit Samorapoompichit, Christian Baumgärtner, F. Y. Lee, Karl J. Aichberger, Paul W. Manley, Doriano Fabbro, Winfried F. Pickl, Christian Sillaber, Peter Valent
Izdano 2007Artigo -
12
High STAT5 levels mediate imatinib resistance and indicate disease progression in chronic myeloid leukemia od Wolfgang Warsch, Karoline Kollmann, Eva Eckelhart, Sabine Fajmann, Sabine Cerny‐Reiterer, Andrea Hölbl, Karoline V. Gleixner, Michael Dworzak, Matthias Mayerhofer, Gregor Hoermann, Harald Herrmann, Christian Sillaber, Gerda Egger, Peter Valent, Richard Moriggl, Veronika Sexl
Izdano 2011Artigo -
13
Identification of mcl-1 as a BCR/ABL-dependent target in chronic myeloid leukemia (CML): evidence for cooperative antileukemic effects of imatinib and mcl-1 antisense oligonucleoti... od Karl J. Aichberger, Matthias Mayerhofer, Maria‐Theresa Krauth, Hans Skvara, Stefan Florian, Karoline Sonneck, Cahit Akgul, Sophia Derdak, Winfried F. Pickl, Volker Wacheck, Edgar Selzer, Brett P. Monia, Richard Moriggl, Peter Valent, Christian Sillaber
Izdano 2004Artigo -
14
Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia od Harald Herrmann, Irina Sadovnik, Sabine Cerny‐Reiterer, Thomas Rülicke, Gabriele Stefanzl, Michael Willmann, Gregor Hoermann, Martin Bilban, Katharina Blatt, Susanne Herndlhofer, Matthias Mayerhofer, Berthold Streubel, Wolfgang R. Sperr, Tessa L. Holyoake, Christine Mannhalter, Peter Valent
Izdano 2014Artigo -
15
KIT-D816V–independent oncogenic signaling in neoplastic cells in systemic mastocytosis: role of Lyn and Btk activation and disruption by dasatinib and bosutinib od Karoline V. Gleixner, Matthias Mayerhofer, Sabine Cerny‐Reiterer, G Hörmann, Uwe Rix, Keiryn L. Bennett, Emir Hadzijusufovic, Renata A. Meyer, Winfried F. Pickl, Jason Gotlib, Hans‐Peter Horny, Andreas Reiter, Gerlinde Mitterbauer‐Hohendanner, Giulio Superti‐Furga, Peter Valent
Izdano 2011Artigo -
16
Identification of the Ki-1 antigen (CD30) as a novel therapeutic target in systemic mastocytosis od Katharina Blatt, Sabine Cerny‐Reiterer, Juliana Schwaab, Karl Sotlar, Gregor Eisenwort, Gabriele Stefanzl, Gregor Hoermann, Matthias Mayerhofer, Mathias Schneeweiss‐Gleixner, Sylvia Knapp, Thomas Rülicke, Emir Hadzijusufovic, Karin Bauer, Dubravka Smiljkovic, Michael Willmann, Andreas Reiter, Hans‐Peter Horny, Peter Valent
Izdano 2015Artigo -
17
Targeting of heat shock protein 32 (Hsp32)/heme oxygenase-1 (HO-1) in leukemic cells in chronic myeloid leukemia: a novel approach to overcome resistance against imatinib od Matthias Mayerhofer, Karoline V. Gleixner, Julia Mayerhofer, Gregor Hoermann, Eva Jaeger, Karl J. Aichberger, René G. Ott, Khaled Greish, Hideaki Nakamura, Sophia Derdak, Puchit Samorapoompichit, Winfried F. Pickl, Veronika Sexl, Harald Esterbauer, Ilse Schwarzinger, Christian Sillaber, Hiroshi Maeda, Peter Valent
Izdano 2007Artigo -
18
Unique Effects of KIT D816V in BaF3 Cells: Induction of Cluster Formation, Histamine Synthesis, and Early Mast Cell Differentiation Antigens od Matthias Mayerhofer, Karoline V. Gleixner, Andrea Hoelbl‐Kovacic, Stefan Florian, Gregor Hoermann, Karl J. Aichberger, Martin Bilban, Harald Esterbauer, Maria‐Theresa Krauth, Wolfgang R. Sperr, Jack Longley, Róbert Královics, Richard Moriggl, Jacques Zappulla, Roland Liblau, Ilse Schwarzinger, Veronika Sexl, Christian Sillaber, Peter Valent
Izdano 2008Artigo -
19
Pathogenesis and classification of eosinophil disorders: a review of recent developments in the field od Peter Valent, Gerald J. Gleich, Andreas Reiter, Florence Roufosse, Peter F. Weller, Andrzej Hellmann, Georgia Metzgeroth, Kristin M. Leiferman, Michel Arock, Karl Sotlar, Joseph H. Butterfield, Sabine Cerny‐Reiterer, Matthias Mayerhofer, Peter Vandenberghe, Torsten Haferlach, Bruce S. Bochner, Jason Gotlib, Hans‐Peter Horny, Hans‐Uwe Simon, Amy D. Klion
Izdano 2012Revisão -
20
A Kinase-Independent Function of CDK6 Links the Cell Cycle to Tumor Angiogenesis od Karoline Kollmann, Gerwin Heller, Christine Schneckenleithner, Wolfgang Warsch, Ruth Scheicher, René G. Ott, Markus Schäfer, Sabine Fajmann, Michaela Schlederer, Ana‐Iris Schiefer, Ursula Reichart, Matthias Mayerhofer, Christoph Höeller, Sabine Zöchbauer‐Müller, Dontscho Kerjaschki, Christoph Bock, Lukas Kenner, Gerald Höefler, Michael Freissmuth, Anthony R. Green, Richard Moriggl, Meinrad Busslinger, Marcos Malumbres, Veronika Sexl
Izdano 2013Errata/Corrigenda
Iskalna orodja:
Sorodne teme
Biology
Cancer research
Immunology
Cell biology
Medicine
Myeloid leukemia
Imatinib
Biochemistry
Tyrosine kinase
Cancer
Mast cell
Signal transduction
Systemic mastocytosis
Gene
Genetics
Internal medicine
Leukemia
Receptor
Pharmacology
Chemistry
Imatinib mesylate
Nilotinib
ABL
Cell
Dasatinib
Haematopoiesis
K562 cells
Stem cell
Tyrosine-kinase inhibitor
breakpoint cluster region